Wondfo Biologics: Correction Announcement on the 2025 Semi-annual Report
Securities code: 300482 Securities abbreviation: Wondfo Biotechnology Announcement number: 2025-052
Bond code: 123064 Bond abbreviation: Wondfo Convertible Bonds
Guangzhou Wondfo Biotechnology Co., Ltd.
Correction announcement regarding the 2025 semi-annual report
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and that there are no false records.
information, misleading statements or material omissions.
Special tips:
Guangzhou Wondfo Biotechnology Co., Ltd. (hereinafter referred to as the "Company") on August 20, 2025
The "2025 Semi-Annual Report" was disclosed on the Juchao Information Network (http://www.cninfo.com.cn). by
The verification found that "3. Number of shareholders and shareholding status of the company" in "Section 6" of the 2025 semi-annual report
Some of the information in the middle was entered incorrectly. The correction is as follows:
Before correction:
Holders of special voting rights at the end of the reporting period resume special voting
Total number of preferred stock shareholders Total number of ordinary shareholders at the end of the reporting period 44,867 0 0 Number (if any) (see Note 8 of shareholders) Total number (if any) Shareholdings of shareholders holding more than 5% or the top 10 shareholders (excluding shares lent through refinancing)
Reporting period: Held: No: Pledged, marked or frozen Reporting period
Shareholder nature Shareholding ratio Internal increase or decrease Sales restriction clause Sales restriction clause
Name of shareholder Last shareholding
Quality Example Change of shares of the case Share status Quantity Quantity
Condition Quantity of copies Quantity of copies
Within the territory from 97,843, 97,843,
Li Wenmei 20.32% 0.00 0 Not applicable 0 Ranren 968.00 968.00
Within the territory from 49,594, 37,196, 12,398,
Wang Jihua 10.30% 0.00 Not applicable 0
Ranren 740.00 055.00 685.00
Guangzhou Huiyin Tianyue
State law 49,195, 49,195,
Equity investment fund 10.22% 0.00 0 Frozen 22,230,000.00
Person 579.00 579.00
Management Co., Ltd.
Bank of China shares
Co., Ltd. - Hua
Baozhongzheng Medical Exchange 9,555,0 -51,900 9,555,0
Others 1.98% 0 Not applicable 0 Easy open-ended index 07.00 .00 07.00
Digital securities investment fund
gold
Guangzhou Biomedicine
State law 9,018,0 9,018,0
Investment in health industry 1.87% 0.00 0 Not applicable 0
Person 88.00 88.00
Capital Co., Ltd.
Guangdong Hengkuo Investment State-owned Law 5,881,5 5,881,5
1.22% 0.00 0 Not applicable 0 Management Co., Ltd. Person 68.00 68.00
Sequoia Jincheng (Xiamen, China, Africa)
4,323,0 4,323,0
(Door) Equity Investment State-Owned Law 0.90% 0.00 0 Not applicable 0
29.00 29.00
partnership (limited partnership)
Guy)
Domestic from 3,950,0 3,950,0 3,950,0
Weng Xuejun 0.82% 0 Not applicable 0
Ranren 00.00 00.00 00.00
Hong Kong Securities Clearing Company Offshore Law 2,666,5 -139,42 2,666,5
0.55% 0 Not applicable 0 Limited Company Person 59.00 1.00 59.00
China Merchants Bank
Ltd - South
Fang Zhongzheng 1000 2,665,1 2,665,1 2,665,1
Others 0.55% 0 Not applicable 0 Easy open-ended index 00.00 00.00 00.00
Digital securities investment fund
gold
Strategic investors or general legal persons
Placing new shares to become the top 10 shareholders None
circumstances (if any) (see Note 3)
The above-mentioned shareholders are related or consistent. Natural persons Li Wenmei and Wang Jihua are the controlling shareholders and actual controllers of the company. In total, they directly hold 147,438,708 shares of the company, accounting for 30.62% of the company's total share capital.
The above-mentioned shareholders are involved in the entrustment/trustee table
of voting rights and renunciation of voting rights None
Ming
Among the top 10 shareholders, there are buyback specialties
None
Special instructions for households (see Note 11)
Shareholdings of the top 10 shareholders without sales restrictions (excluding shares lent through refinancing and shares locked by executives)
Share type
Name of shareholder Number of shares without selling restrictions held at the end of the reporting period
Type of shares Quantity Li Wenmei 97,843,968.00 RMB ordinary shares 97,843,968.00 Guangzhou Huiyin Tianyue Equity Investment Fund
49,195,579.00 RMB ordinary shares 49,195,579.00 Gold Management Co., Ltd.
Wang Jihua 12,398,685.00 RMB ordinary shares 12,398,685.00 Guangzhou Biomedicine and Health Industry
9,018,088.00 RMB ordinary shares 9,018,088.00 Investment Co., Ltd.
Bank of China Co., Ltd.-
Huabao CSI Medical Trading Open 8,864,807.00 RMB ordinary shares 8,864,807.00 Index Securities Investment Fund
Guangdong Hengkuo Investment Management Co., Ltd.
5,881,568.00 RMB ordinary shares 5,881,568.00 Company
Sequoia Jincheng (Xiamen) Equity Investment
4,323,029.00 RMB ordinary shares 4,323,029.00 Partnership (limited partnership)
Weng Xuejun 4,300,000.00 RMB ordinary shares 4,300,000.00 Hong Kong Securities Clearing Company Limited 3,081,886.00 RMB ordinary shares 3,081,886.00 National Social Security Fund 118 Portfolio 2,655,351.00 RMB ordinary shares 2,655,351.00 Top 10 shareholders of unrestricted tradable shares
between, and unlimited sales for the first 10
Natural persons Li Wenmei and Wang Jihua are the company's controlling shareholders and actual controllers. Together, they directly hold the company's tradable shares and the top 10 shareholders.
147,438,708 shares, accounting for 30.62% of the company’s total share capital.
relationship or concerted action
description
The top 10 common shareholders participated in the financing
The shareholder Weng Xuejun holds 350,000 shares in his ordinary account and 3,600,000 shares in his credit account, for a total of 3,950,000 shares. Description of shareholders in the securities financing business
shares
(if any) (see note 4)
After correction:
Voting rights were restored at the end of the reporting period.
Total number of ordinary shareholders at the end of the reporting period 44,867 0 0
The total number of preferred shareholders shall vote separately.
Number (if any) (see registered shares 8) Total number of shareholders (if any)
Shareholding status of shareholders holding more than 5% of the shares or the top 10 shareholders (excluding shares lent through refinancing)
Reporting period: Held: No: Pledged, marked or frozen Reporting period
Shareholder nature Shareholding ratio Internal increase or decrease Sales restriction clause Sales restriction clause
Name of shareholder Last shareholding
Quality Example Change of shares of the case Share status Quantity Quantity
Condition Quantity of copies Quantity of copies
Within the territory from 97,843, 97,843,
Li Wenmei 20.32% 0.00 0 Not applicable 0 Ranren 968.00 968.00
Within the territory from 49,594, 37,196, 12,398,
Wang Jihua 10.30% 0.00 Not applicable 0
Ranren 740.00 055.00 685.00
Guangzhou Huiyin Tianyue
State law 49,195, 49,195,
Equity investment fund 10.22% 0.00 0 Frozen 22,230,000.00
Person 579.00 579.00
Management Co., Ltd.
Bank of China shares
Co., Ltd. - Hua
Baozhongzheng Medical Exchange 9,555,0 -51,900 9,555,0
Others 1.98% 0 Not applicable 0 Easy open-ended index 07.00 .00 07.00
Digital securities investment fund
gold
Guangzhou Biomedicine
State law 9,018,0 9,018,0
Investment in health industry 1.87% 0.00 0 Not applicable 0
Person 88.00 88.00
Capital Co., Ltd.
Guangdong Hengkuo Investment State-owned Law 5,881,5 5,881,5
1.22% 0.00 0 Not applicable 0 Management Co., Ltd. Person 68.00 68.00
Sequoia Jincheng (Xiamen
Domestic non-
door) equity investment total 4,323,0 4,323,0
State-owned law 0.90% 0.00 0 Not applicable 0 enterprises (limited partnership 29.00 29.00
people
Guy)
Domestic from 3,950,0 3,950,0 3,950,0
Weng Xuejun 0.82% 0 Not applicable 0
Ranren 00.00 00.00 00.00
Hong Kong Securities Clearing Company Offshore Law 2,666,5 -139,42 2,666,5
0.55% 0 Not applicable 0 Limited Company Person 59.00 1.00 59.00
China Merchants Bank
Ltd - South
Fang Zhongzheng 1000 2,665,1 2,665,1 2,665,1
Others 0.55% 0 Not applicable 0 Easy open-ended index 00.00 00.00 00.00
Digital securities investment fund
gold
Strategic investors or general legal persons
Placing new shares to become the top 10 shareholders None
circumstances (if any) (see Note 3)
The above-mentioned shareholders are related or consistent. Natural persons Li Wenmei and Wang Jihua are the controlling shareholders and actual controllers of the company. In total, they directly hold 147,438,708 shares of the company, accounting for 30.62% of the company's total share capital.
The above-mentioned shareholders are involved in the entrustment/trustee table
of voting rights and renunciation of voting rights None
Ming
Among the top 10 shareholders, there are buyback specialties
None
Special instructions for households (see Note 11)
Shareholdings of the top 10 shareholders without sales restrictions (excluding shares lent through refinancing and shares locked by executives)
Type of shares Name of shareholder Number of shares without selling restrictions held at the end of the reporting period
Type of shares Quantity Li Wenmei 97,843,968.00 RMB ordinary shares 97,843,968.00 Guangzhou Huiyin Tianyue Equity Investment Fund
49,195,579.00 RMB ordinary shares 49,195,579.00 Gold Management Co., Ltd.
Wang Jihua 12,398,685.00 RMB ordinary shares 12,398,685.00 Bank of China Co., Ltd. -
Huabao CSI Medical Trading Open 9,555,007.00 RMB Ordinary Shares 9,555,007.00 Index Securities Investment Fund
Guangzhou Biomedicine and Health Industry
9,018,088.00 RMB ordinary shares 9,018,088.00 Investment Co., Ltd.
Guangdong Hengkuo Investment Management Co., Ltd.
5,881,568.00 RMB ordinary shares 5,881,568.00 Company
Sequoia Jincheng (Xiamen) Equity Investment
4,323,029.00 RMB ordinary shares 4,323,029.00 Partnership (limited partnership)
Weng Xuejun 3,950,000.00 RMB ordinary shares 3,950,000.00 Hong Kong Securities Clearing Company Limited 2,666,559.00 RMB ordinary shares 2,666,559.00 China Merchants Bank Co., Ltd. -
Southern CSI 1000 Trading Open 2,665,100.00 RMB Ordinary Shares 2,665,100.00 Index Securities Investment Fund
Top 10 shareholders of unrestricted tradable shares
between, and unlimited sales for the first 10
Natural persons Li Wenmei and Wang Jihua are the company's controlling shareholders and actual controllers. Together, they directly hold the company's tradable shares and the top 10 shareholders.
147,438,708 shares, accounting for 30.62% of the company’s total share capital.
relationship or concerted action
description
The top 10 common shareholders participated in the financing
The shareholder Weng Xuejun holds 350,000 shares in his ordinary account and 3,600,000 shares in his credit account, for a total of 3,950,000 shares. Description of shareholders in the securities financing business
shares
(if any) (see note 4)
Except for the above corrections, other contents of the company's "2025 Semi-Annual Report" remain unchanged. The above updates
It does not involve changes to financial indicator data, and will not affect the company's 2025 semi-annual report financial status and operating results.
consequences. For details of the corrected "2025 Semi-Annual Report", please see the cninfo.com.cn
(http://www.cninfo.com.cn). The company deeply apologizes for the inconvenience caused to investors due to this correction.
We sincerely apologize to investors for their understanding. In the future, the company will further strengthen the review of information disclosure documents and improve
High quality of information disclosure.
Announcement is hereby made.
Guangzhou Wondfo Biotechnology Co., Ltd.
board of directors
September 23, 2025